Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8–substrate complex
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDACs)-an enzyme family that deacetylates histones and non-histone proteins-are implicated in human diseases such as cancer, and the first-generation of HDAC inhibitors are now in clinical trials. Here, we report the 2.0 A resolution crystal structure of a catalytically inactive HDAC8 active-site mutant, Tyr306Phe, bound to an acetylated peptidic substrate. The structure clarifies the role of active-site residues in the deacetylation reaction and substrate recognition. Notably, the structure shows the unexpected role of a conserved residue at the active-site rim, Asp 101, in positioning the substrate by directly interacting with the peptidic backbone and imposing a constrained cis-conformation. A similar interaction is observed in a new hydroxamate inhibitor-HDAC8 structure that we also solved. The crucial role of Asp 101 in substrate and inhibitor recognition was confirmed by activity and binding assays of wild-type HDAC8 and Asp101Ala, Tyr306Phe and Asp101Ala/Tyr306Phe mutants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, D94 corresponds to acetyllysine binding residues D101 of hHDAC8 and S568 of hHDAC6 CD2 (refs 17, 30, 31).”
From Histone deacetylase 10 structure and molecular function as a polyamine deacetylase (2017) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In HDAC8, highly conserved D101 accepts hydrogen bonds from the two backbone amide groups flanking the scissile acetyllysine residue.37,38”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [37]
In the citing paper
“Crystal structures of human HDAC8, in complex with different inhibitors, have been reported; they revealed a single α/β-domain with a core eight-stranded parallel β-sheet and 11 α-helices.7, 31, 32”
From HDAC8 catalyzes the hydrolysis of long chain fatty acyl lysine (2016) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742 · cited 1×
“Model building was carried out using QUANTA2000 (Accelrys, Cambridge, UK) and refinement with REFMAC (Murshudov et al, 1997).”
MethodPRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845 · cited 1×
“Acetylation status of the lysine residue at the N-terminal extensions of core histones is controlled by two counteracting enzymes: histone acetyl transferases and histone deacetylases (HDACs; Roth et al, 2001; Marks et al, 2003).”
BackgroundStructures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714 · cited 6×
“The HDAC8 active site (Somoza et al, 2004; Vannini et al, 2004) presents features of both serine and zinc proteases, and contains two His–Asp dyads with both histidine residues supposed to work as a general acid–base catalytic pair, as originally proposed for HDLP and extended to HDAH (Finnin et al, 1999; Nielsen et a…”
BackgroundResultInfluentialThe Sir2 Family of Protein Deacetylases
Blander, G., & Guarente, L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073651 · Cited by 1,495 · cited 1×
“HDAC11 is distinct from those in classes I and II; therefore, it has been placed in class IV, as class III refers to the unrelated sirtuin deacetylases (Blander & Guarente, 2004).”
BackgroundGregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456 · cited 1×
“Eukaryotic HDACs have been classified into four groups on the basis of phylogenetic analysis (Gregoretti et al, 2004).”
Backgroundp53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776 · cited 2×
“whereas the substrate has no coumarin group, substituted instead with Leu-Met and corresponding to p53 protein sequence 379–384 (Liu et al, 1999).”
BackgroundFischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754 · cited 1×
“The only significant exception is Tyr306, which is histidine in class IIa HDACs (4, 5, 7, 9), which causes a pronounced decrease in catalytic activity on peptidic substrates (Fischle et al, 2002).”
BackgroundStructural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678 · cited 1×
“As these processes are modulated during malignant transformation, HDAC inhibitors are being developed as antineoplastic drugs (Gallinari et al, 2007), and vorinostat was recently approved by the Food and Drug Administration for the treatment of cutaneous T-cell lymphoma.”
BackgroundSelf-citation
Cited by
NCIPLOT: A Program for Plotting Noncovalent Interaction Regions
Contreras-García, J., Johnson, E. R., Keinan, S., Chaudret, R., Piquemal, J.-P., Beratan, D. N., & Yang, W. (2011) · Journal of Chemical Theory and Computation · doi:10.1021/ct100641a · Cited by 4,076
Class I histone deacetylases (HDAC1–3) are histone lysine delactylases
Moreno-Yruela, C., Zhang, D., Wei, W., Bæk, M., Liu, W., Gao, J., Danková, D., Nielsen, A. L., Bolding, J. E., Yang, L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abi6696 · Cited by 841
“For example, SIRT5 is an efficient lysine demalonylase, desuccinylase, and deglutarylase but not deacetylase (25–28), and HDAC8, HDAC11, SIRT2, and SIRT6 harbor substantial activities against long chain acyl modifications (29–33).”
BackgroundInfluentialHDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
Hai, Y., & Christianson, D. W. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2134 · Cited by 521
“37,38 However, the corresponding residue in zCD2, N530, was offset such that S531 of zCD2 structurally aligned with D101 of HDAC8 and accepted a hydrogen bond from the backbone NH group of acetyllysine in substrates 1 and 8 (Fig.”
Chemical mechanisms of histone lysine and arginine modifications
Smith, B. C., & Denu, J. M. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.06.005 · Cited by 390
“In the first chemical step, both His-142 [83–85,88] and His-143 [87] have been implicated as the general base that activates the water molecule for nucleophilic attack of the acetyl carbonyl carbon.”
BackgroundInfluentialLysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366
Inside HDAC with HDAC inhibitors
Bertrand, P. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.02.030 · Cited by 363
Bottomley, M. J., Lo Surdo, P., Di Giovine, P., Cirillo, A., Scarpelli, R., Ferrigno, F., Jones, P., Neddermann, P., De Francesco, R., Steinkühler, C., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803514200 · Cited by 312
Self-citationWei, W., Liu, X., Chen, J., Gao, S., Lu, L., Zhang, H., Ding, G., Wang, Z., Chen, Z., Shi, T., et al. (2017) · Cell Research · doi:10.1038/cr.2017.68 · Cited by 304
HDAC8: a multifaceted target for therapeutic interventions
Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R. J., & Jung, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.013 · Cited by 284
Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes
Lombardi, P. M., Cole, K. E., Dowling, D. P., & Christianson, D. W. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.08.004 · Cited by 277
“While H142 was initially proposed to be the general base [13, 31], this proposal is not supported by the residual activity and pH-rate dependence of H142A HDAC8 [37].”
BackgroundResultInfluentialSchuetz, A., Min, J., Allali-Hassani, A., Schapira, M., Shuen, M., Loppnau, P., Mazitschek, R., Kwiatkowski, N. P., Lewis, T. A., Maglathin, R. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707362200 · Cited by 257
Sun, Z., Feng, D., Fang, B., Mullican, S. E., You, S.-H., Lim, H.-W., Everett, L. J., Nabel, C. S., Li, Y., Selvakumaran, V., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.022 · Cited by 247
“The same Y > F substitution in HDAC8 was also inactivating and was used to crystallize the substrate-bound HDAC8, because the enzyme failed to finish the catalytic transition and trapped its substrate in the catalytic pocket (Vannini et al., 2007).”
Insights into the activation mechanism of class I HDAC complexes by inositol phosphates
Watson, P. J., Millard, C. J., Riley, A. M., Robertson, N. S., Wright, L. C., Godage, H. Y., Cowley, S. M., Jamieson, A. G., Potter, B. V. L., & Schwabe, J. W. R. (2016) · Nature Communications · doi:10.1038/ncomms11262 · Cited by 244
Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis
Wilting, R. H., Yanover, E., Heideman, M. R., Jacobs, H., Horner, J., van der Torre, J., DePinho, R. A., & Dannenberg, J. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.136 · Cited by 226
Tcf1 and Lef1 transcription factors establish CD8+ T cell identity through intrinsic HDAC activity
Xing, S., Li, F., Zeng, Z., Zhao, Y., Yu, S., Shan, Q., Li, Y., Phillips, F. C., Maina, P. K., Qi, H. H., et al. (2016) · Nature Immunology · doi:10.1038/ni.3456 · Cited by 229
“We used HDAC8 as a template, because high-resolution HDAC8 27 , substrate-HDAC8 28 and ligand-HDAC8 29 structures are available.”
Inhibitors of histone deacetylase as antitumor agents: A critical review
Manal, M., Chandrasekar, M. J. N., Gomathi Priya, J., & Nanjan, M. J. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.05.005 · Cited by 216
Dowling, D. P., Gantt, S. L., Gattis, S. G., Fierke, C. A., & Christianson, D. W. (2008) · Biochemistry · doi:10.1021/bi801610c · Cited by 200
“One is within hydrogen-bonding distance to the Y306 hydroxyl group, while the other is within hydrogenbonding distance to both H142 and H143.”
InfluentialHistone deacetylase 10 structure and molecular function as a polyamine deacetylase
Hai, Y., Shinsky, S. A., Porter, N. J., & Christianson, D. W. (2017) · Nature Communications · doi:10.1038/ncomms15368 · Cited by 200
Histone deacetylases: structural determinants of inhibitor selectivity
Micelli, C., & Rastelli, G. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.007 · Cited by 192
Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites
Bougdour, A., Maubon, D., Baldacci, P., Ortet, P., Bastien, O., Bouillon, A., Barale, J.-C., Pelloux, H., Ménard, R., & Hakimi, M.-A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082826 · Cited by 191
Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors
Porter, N. J., Mahendran, A., Breslow, R., & Christianson, D. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718823114 · Cited by 190
“hydrogen bonds from both backbone NH groups flanking the scissile acetyl–L-lysine residue (44, 45).”
BackgroundMethot, J. L., Chakravarty, P. K., Chenard, M., Close, J., Cruz, J. C., Dahlberg, W. K., Fleming, J., Hamblett, C. L., Hamill, J. E., Harrington, P., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.031 · Cited by 191
Marek, L., Hamacher, A., Hansen, F. K., Kuna, K., Gohlke, H., Kassack, M. U., & Kurz, T. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301254q · Cited by 177
Electric Fields in Catalysis: From Enzymes to Molecular Catalysts
Léonard, N. G., Dhaoui, R., Chantarojsiri, T., & Yang, J. Y. (2021) · ACS Catalysis · doi:10.1021/acscatal.1c02084 · Cited by 178
Survey of the year 2007 commercial optical biosensor literature
Rich, R. L., & Myszka, D. G. (2008) · Journal of Molecular Recognition · doi:10.1002/jmr.928 · Cited by 178
Marek, M., Kannan, S., Hauser, A.-T., Moraes Mourão, M., Caby, S., Cura, V., Stolfa, D. A., Schmidtkunz, K., Lancelot, J., Andrade, L., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003645 · Cited by 173
Suzuki, T., Ota, Y., Ri, M., Bando, M., Gotoh, A., Itoh, Y., Tsumoto, H., Tatum, P. R., Mizukami, T., Nakagawa, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300837y · Cited by 165
Kaiser, F. J., Ansari, M., Braunholz, D., Concepción Gil-Rodríguez, M., Decroos, C., Wilde, J. J., Fincher, C. T., Kaur, M., Bando, M., Amor, D. J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu002 · Cited by 154
“1B) that exhibits moderate flexibility in the binding of substrates and inhibitors (27,30,33,34).”
BackgroundMethodInfluentialBürli, R. W., Luckhurst, C. A., Aziz, O., Matthews, K. L., Yates, D., Lyons, K. A., Beconi, M., McAllister, G., Breccia, P., Stott, A. J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4011884 · Cited by 153
Cole, K. E., Dowling, D. P., Boone, M. A., Phillips, A. J., & Christianson, D. W. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205972n · Cited by 153
Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases
Porter, N. J., & Christianson, D. W. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.01.004 · Cited by 146
A Proton-Shuttle Reaction Mechanism for Histone Deacetylase 8 and the Catalytic Role of Metal Ions
Wu, R., Wang, S., Zhou, N., Cao, Z., & Zhang, Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103932d · Cited by 134
Marek, M., Shaik, T. B., Heimburg, T., Chakrabarti, A., Lancelot, J., Ramos-Morales, E., Da Veiga, C., Kalinin, D., Melesina, J., Robaa, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01087 · Cited by 122
HDAC8 catalyzes the hydrolysis of long chain fatty acyl lysine
Aramsangtienchai, P., Spiegelman, N. A., He, B., Miller, S. P., Dai, L., Zhao, Y., & Lin, H. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00396 · Cited by 118
Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
Banerjee, S., Adhikari, N., Amin, S. A., & Jha, T. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.039 · Cited by 108
A Genetically Encoded, Phage‐Displayed Cyclic‐Peptide Library
Wang, X. S., Chen, P. C., Hampton, J. T., Tharp, J. M., Reed, C. A., Das, S. K., Wang, D., Hayatshahi, H. S., Shen, Y., Liu, J., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201908713 · Cited by 125
Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases
Chakrabarti, A., Melesina, J., Kolbinger, F. R., Oehme, I., Senger, J., Witt, O., Sippl, W., & Jung, M. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0117 · Cited by 111
Yang, Z., Wang, T., Wang, F., Niu, T., Liu, Z., Chen, X., Long, C., Tang, M., Cao, D., Wang, X., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01342 · Cited by 108
Wu, R., Lu, Z., Cao, Z., & Zhang, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111104p · Cited by 108
Neelarapu, R., Holzle, D. L., Velaparthi, S., Bai, H., Brunsteiner, M., Blond, S. Y., & Petukhov, P. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2001025 · Cited by 117
“3-Azido-5-hydroxymethylbenzoic acid methyl ester (10)—To an ice cooled solution of amino-ester 9 (3 g, 16.”
MethodSmall Molecule Inhibitors of Zinc-dependent Histone Deacetylases
Wagner, F. F., Weïwer, M., Lewis, M. C., & Holson, E. B. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0226-1 · Cited by 107
Transcription and beyond: the role of mammalian class I lysine deacetylases
Moser, M., Hagelkrüys, A., & Seiser, C. (2013) · Chromosoma · doi:10.1007/s00412-013-0441-x · Cited by 103
“Complexes and modifications of class I KDACs HDAC1 and HDAC2 can homo- and hetero-dimerize (Hassig et al. 1998; Taplick et al. 2001), while HDAC3 forms homo- oligomers (Gregoretti et al. 2004; Yang et al. 2002) and HDAC8 is found as a dimer (Vannini et al. 2004, 2007).”
BackgroundThaler, F., & Mercurio, C. (2014) · ChemMedChem · doi:10.1002/cmdc.201300413 · Cited by 95
Small-molecule microarrays as tools in ligand discovery
Vegas, A. J., Fuller, J. H., & Koehler, A. N. (2008) · Chemical Society Reviews · doi:10.1039/b703568n · Cited by 94
Heimburg, T., Kolbinger, F. R., Zeyen, P., Ghazy, E., Herp, D., Schmidtkunz, K., Melesina, J., Shaik, T. B., Erdmann, F., Schmidt, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01447 · Cited by 92
Activation and Inhibition of Histone Deacetylase 8 by Monovalent Cations
Gantt, S. L., Joseph, C. G., & Fierke, C. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033399 · Cited by 86
On the inhibition of histone deacetylase 8
Estiu, G., West, N., Mazitschek, R., Greenberg, E., Bradner, J. E., & Wiest, O. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.080 · Cited by 82
HDAC8 and STAT3 repress BMF gene activity in colon cancer cells
Kang, Y., Nian, H., Rajendran, P., Kim, E., Dashwood, W. M., Pinto, J. T., Boardman, L. A., Thibodeau, S. N., Limburg, P. J., Löhr, C. V., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.422 · Cited by 82
HDAC8 substrates: Histones and beyond
Wolfson, N. A., Pitcairn, C. A., & Fierke, C. A. (2013) · Biopolymers · doi:10.1002/bip.22135 · Cited by 80
Núñez‐Álvarez, Y., & Suelves, M. (2021) · FEBS Journal · doi:10.1111/febs.15895 · Cited by 95
Stimulation of Histone Deacetylase Activity by Metabolites of Intermediary Metabolism
Vogelauer, M., Krall, A. S., McBrian, M. A., Li, J.-Y., & Kurdistani, S. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362467 · Cited by 81
“The corresponding residue in HDAC8, Asp-183, has been shown to take part in the catalytic charge-relay system (33).”
BackgroundDowling, D. P., Gattis, S. G., Fierke, C. A., & Christianson, D. W. (2010) · Biochemistry · doi:10.1021/bi1005046 · Cited by 81
“(d) First step in the proposed HDAC8 mechanism (21, 36, 47).”
Epigenetic mechanisms regulate stage differentiation in the minimized protozoan Giardia lamblia
Sonda, S., Morf, L., Bottová, I., Baetschmann, H., Rehrauer, H., Caflisch, A., Hakimi, M., & Hehl, A. B. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07062.x · Cited by 86
“This suggests that regulation of histone acetylation is involved in the control of Giardia stage differentiation, and identifies epigenetic mechanisms as a promising target to prevent Giardia transmission.”
BackgroundDesign, Synthesis, and Biological Activity of Boronic Acid-Based Histone Deacetylase Inhibitors
Suzuki, N., Suzuki, T., Ota, Y., Nakano, T., Kurihara, M., Okuda, H., Yamori, T., Tsumoto, H., Nakagawa, H., & Miyata, N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900125m · Cited by 77
Wu, R., Hu, P., Wang, S., Cao, Z., & Zhang, Y. (2009) · Journal of Chemical Theory and Computation · doi:10.1021/ct9005322 · Cited by 86
Pathological Role of HDAC8: Cancer and Beyond
Kim, J. Y., Cho, H., Yoo, J. H., Kim, G. W., Jeon, Y. H., Lee, S. W., & Kwon, S. H. (2022) · Cells · doi:10.3390/cells11193161 · Cited by 92
“(A) Head-to-head dimeric arrangement of HDAC8 (PDB ID: 2V5W [27]).”
Trans-regulation of Histone Deacetylase Activities through Acetylation
Luo, Y., Jian, W., Stavreva, D., Fu, X., Hager, G., Bungert, J., Huang, S., & Qiu, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038356 · Cited by 78
Anantharaju, P. G., Reddy, D. B., Mahesh, P. A., Chitturi, C. M. K., Vimalambike, M. G., & Madhunapantula, S. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186208 · Cited by 85
Vanaja, G. R., Ramulu, H. G., & Kalle, A. M. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0231-4 · Cited by 74
Rodrigues, D. A., Pinheiro, P. D. S. M., Sagrillo, F. S., Bolognesi, M. L., & Fraga, C. A. M. (2020) · Medicinal Research Reviews · doi:10.1002/med.21701 · Cited by 70
Metabolism as a key to histone deacetylase inhibition
Rajendran, P., Williams, D. E., Ho, E., & Dashwood, R. H. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.557713 · Cited by 78
“…2007; Somoza et al., 2004; Bottomley et al., 2008; Dowling et al., 2008; Schuetz et al., 2008; Ficner, 2009), and computational modeling in silico (Vannini et al., 2007; Nian et al., 2008, 2009b; Ortore et al., 2009; Suzuki et al., 2009; Wang, 2009; Oger et al., 2010), numerous HDAC…”
BackgroundInfluentialStolfa, D. A., Marek, M., Lancelot, J., Hauser, A.-T., Walter, A., Leproult, E., Melesina, J., Rumpf, T., Wurtz, J.-M., Cavarelli, J., et al. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.03.007 · Cited by 75
“pdb [47] for thedocking studies since it gave thebest results in cross-docking of a large library of published and in-house HDAC8 inhibitors (data not shown).”
Mechanism of Action for HDAC Inhibitors—Insights from Omics Approaches
Li, W., & Sun, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071616 · Cited by 81
“HDIs block HDAC enzyme activity by binding to the zinc ion in the catalytic site, which blocks substrate access to the site [11,12].”
BackgroundZinc-dependent Deacetylase (HDAC) Inhibitors with Different Zinc Binding Groups
Li, Y., Wang, F., Chen, X., Wang, J., Zhao, Y., Li, Y., & He, B. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190122144949 · Cited by 80
Binding of the Microbial Cyclic Tetrapeptide Trapoxin A to the Class I Histone Deacetylase HDAC8
Porter, N. J., & Christianson, D. W. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00330 · Cited by 71
Evolution of the arginase fold and functional diversity
Dowling, D. P., Di Costanzo, L., Gennadios, H. A., & Christianson, D. W. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7554-z · Cited by 74
Innovative Strategies for Selective Inhibition of Histone Deacetylases
Maolanon, A. R., Madsen, A. S., & Olsen, C. A. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.06.011 · Cited by 72
Modulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
Woan, K. V., Sahakian, E., Sotomayor, E. M., Seto, E., & Villagra, A. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.96 · Cited by 69
General Base–General Acid Catalysis in Human Histone Deacetylase 8
Gantt, S. M. L., Decroos, C., Lee, M. S., Gullett, L. E., Bowman, C. M., Christianson, D. W., & Fierke, C. A. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01327 · Cited by 67
HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals
An, P., Chen, F., Li, Z., Ling, Y., Peng, Y., Zhang, H., Li, J., Chen, Z., & Wang, H. (2020) · Oncogene · doi:10.1038/s41388-020-1337-x · Cited by 68
“inactive HDAC8 according to previous studies [19, 20].”
Morgenstern, A., Jaszai, M., Eberhart, M. E., & Alexandrova, A. N. (2017) · Chemical Science · doi:10.1039/c7sc01301a · Cited by 71
Decroos, C., Bowman, C. M., Moser, J.-A. S., Christianson, K. E., Deardorff, M. A., & Christianson, D. W. (2014) · ACS Chemical Biology · doi:10.1021/cb5003762 · Cited by 66
Andreoli, F., Barbosa, A. J. M., Parenti, M. D., & Río, A. D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804581918 · Cited by 68
Thangapandian, S., John, S., Sakkiah, S., & Woo, L. K. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.07.007 · Cited by 68
Non-Natural Macrocyclic Inhibitors of Histone Deacetylases: Design, Synthesis, and Activity
Auzzas, L., Larsson, A., Matera, R., Baraldi, A., Deschênes-Simard, B., Giannini, G., Cabri, W., Battistuzzi, G., Gallo, G., Ciacci, A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101092u · Cited by 63
Azetidinones as Zinc‐Binding Groups to Design Selective HDAC8 Inhibitors
Galletti, P., Quintavalla, A., Ventrici, C., Giannini, G., Cabri, W., Penco, S., Gallo, G., Vincenti, S., & Giacomini, D. (2009) · ChemMedChem · doi:10.1002/cmdc.200900309 · Cited by 61
Tabackman, A. A., Frankson, R., Marsan, E. S., Perry, K., & Cole, K. E. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2016.06.023 · Cited by 60
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript D101, which functions in substrate binding (Vannini et al., 2007; Dowling et al., 2008).”
BackgroundBallante, F., & Marshall, G. R. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00603 · Cited by 66
Inhibition and Mechanism of HDAC8 Revisited
Chen, K., Zhang, X., Wu, Y.-D., & Wiest, O. (2014) · Journal of the American Chemical Society · doi:10.1021/ja501548p · Cited by 61
Decroos, C., Clausen, D. J., Haines, B. E., Wiest, O., Williams, R. M., & Christianson, D. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00010 · Cited by 58
JONES, P. G., Altamura, S., Francesco, R. D., Paz, O. G., Kinzel, O. D., Mesiti, G., Monteagudo, E. S., Pescatore, G., Rowley, M., Verdirame, M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800079s · Cited by 60
Self-citationThe Activity of HDAC8 Depends on Local and Distal Sequences of Its Peptide Substrates
Gurard-Levin, Z. A., & Mrksich, M. (2008) · Biochemistry · doi:10.1021/bi800053v · Cited by 55
A Transferable Nonbonded Pairwise Force Field to Model Zinc Interactions in Metalloproteins
Wu, R., Lu, Z., Cao, Z., & Zhang, Y. (2011) · Journal of Chemical Theory and Computation · doi:10.1021/ct100525r · Cited by 53
Charrier, C., Clarhaut, J. A., Gesson, J., Estiu, G. L., Wiest, O., Roche, J., & Bertrand, P. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9002439 · Cited by 56
Structure-Based Identification of HDAC8 Non-histone Substrates
Alam, N., Zimmerman, L., Wolfson, N. A., Joseph, C. G., Fierke, C. A., & Schueler-Furman, O. (2016) · Structure · doi:10.1016/j.str.2016.02.002 · Cited by 52
“Structures are based on PDB id 2v5w (Vannini et al., 2007), and rendered using PyMOL (http://www.pymol.org).”
InfluentialWang, D. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609788085287 · Cited by 54
“The critical role of Asp101 in substrate binding and interaction with inhibitors was confirmed by lowered enzymatic activity and in binding assays of Asp101 mutants of HDAC8 [21].”
BackgroundMangiatordi, G. F., Intranuovo, F., Delre, P., Abatematteo, F. S., Abate, C., Niso, M., Creanza, T. M., Ancona, N., Stefanachi, A., & Contino, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01357 · Cited by 52
Bai, H., Velaparthi, S., Pieffet, G. P., Pennington, C., Mahesh, A., Holzle, D. L., Brunsteiner, M., van Breemen, R. B., Blond, S. Y., & Petukhov, P. A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9005077 · Cited by 48
Giannini, G., Vesci, L., Battistuzzi, G., Vignola, D., Milazzo, F. M., Guglielmi, M. B., Barbarino, M., Santaniello, M., Fantò, N., Mor, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008209 · Cited by 52
Energy based pharmacophore mapping of HDAC inhibitors against class I HDAC enzymes
Kalyaanamoorthy, S., & Chen, Y. P. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.08.009 · Cited by 48
“These bonding networks identified in our docked complexes are similar to several other experimental & theoretical studies [29,81].”
ResultEpigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
Elmallah, M. I. Y., & Micheau, O. (2019) · Cancers · doi:10.3390/cancers11060850 · Cited by 53
“Furthermore, activation of the nucleophile is mediated by the general base character of the adjacent His142 and His134 residues in the substrate binding site, which are influenced by hydrogen bonding with Asp176 and Asp183, respectively [33].”
BackgroundThangapandian, S., John, S., Lee, Y., Kim, S., & Lee, K. W. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129440 · Cited by 47
“To date 18 crystal structures were determined by various research groups among which only 8 are native HDAC8 bound with different inhibitors [23,39–42].”
BackgroundSmall-molecular modulators of cancer-associated epigenetic mechanisms
Itoh, Y., Suzuki, T., & Miyata, N. (2013) · Molecular BioSystems · doi:10.1039/c3mb25410k · Cited by 44
Decroos, C., Christianson, N. H., Gullett, L. E., Bowman, C. M., Christianson, K. E., Deardorff, M. A., & Christianson, D. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00881 · Cited by 46
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
Fontana, A., Cursaro, I., Carullo, G., Gemma, S., Butini, S., & Campiani, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710014 · Cited by 50
“H142 serves as the general base catalyst, whereas H143 serves as both the general acid and the general base catalyst (Figure 1) [15,16].”
BackgroundMelesina, J., Robaa, D., Pierce, R. J., Romier, C., & Sippl, W. (2015) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2015.10.006 · Cited by 51
HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation
Nalawansha, D. A., Gomes, I. D., Wambua, M. K., & Pflum, M. K. H. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.03.008 · Cited by 48
Hou, X., Du, J., Liu, R., Zhou, Y., Li, M., Xu, W., & Fang, H. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500762z · Cited by 44
Melino, S., Nepravishta, R., Bellomaria, A., Marco, S. D., & Paci, M. (2008) · Biochemistry · doi:10.1021/bi801407w · Cited by 44
“(38) and by our experimental results using the deacetylated Fluor de-Lys (see Figure 8S of the Supporting Information).”
Metadata
- Authors
- Vannini, A., Volpari, C., Gallinari, P., Jones, P., Mattu, M., Carfí, A., De Francesco, R., Steinkühler, C., & Di Marco, S.
- Affiliations
- Institute of Molecular Biology and Pathology (IT)
- Venue
- The EMBO Reports
- Published
- 2007-08-10
- Volume
- 8
- Issue
- 9
- Pages
- 879-884
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1973954
- OpenAlex
- W2164806419
- Cited by
- 256
- References
- 27
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 12 · 2020: 13 · 2019: 16 · 2018: 14 · 2017: 18 · 2016: 21 · 2015: 14 · 2014: 16 · 2013: 16 · 2012: 17
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Keywords
- HDAC8, substrate binding, active site residues, hydroxamate inhibitors, substrate recognition, catalytically inactive mutant, histone deacetylase inhibitors
- MeSH terms
- Aspartic Acid, Enzyme Inhibitors, Histone Deacetylases, Humans, Models, Molecular, Repressor Proteins, Structure-Activity Relationship, Substrate Specificity, Protein Structure, Secondary, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.